Pseudomonas aeruginosa biofilm: Potential therapeutic targets

Biologicals

Volumn 42, Issue 1, 2014, Pages 1-7

  Sharma, Garima ^a   Rao, Saloni ^a   Bansal, Ankiti ^a   Dang, Shweta ^a   Gupta, Sanjay ^a   Gabrani, Reema ^a  

^a JAYPEE INSTITUTE OF INFORMATION TECHNOLOGY   (India)

Author keywords

Biofilm; Exopolysaccharides (EPS); Nanoparticles; Pseudomonas aeruginosa; Small molecule inhibitors; Therapeutics

Indexed keywords

AJOENE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ARYLDIALKYLPHOSPHATASE; CATHELICIDIN; CIPROFLOXACIN; ERYTHROSINE; EXOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; N ACYLHOMOSERINE LACTONE; NANOPARTICLE; PENICILLIN DERIVATIVE; PEPTOID; PHENOL DERIVATIVE; PLANT MEDICINAL PRODUCT; POLYPEPTIDE ANTIBIOTIC AGENT; PYOCIN;

ANTIBIOTIC RESISTANCE; BACTEREMIA; BACTERIAL VIRULENCE; BACTERIOPHAGE; BACTERIUM ADHERENCE; BIOFILM; HOSPITAL INFECTION; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; OPERON; PHOTODYNAMIC THERAPY; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; QUORUM SENSING; REVIEW; TYPE III SECRETION SYSTEM; URINARY TRACT INFECTION;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; PSEUDOMONAS AERUGINOSA;

BIOFILM; EXOPOLYSACCHARIDES (EPS); NANOPARTICLES; PSEUDOMONAS AERUGINOSA; SMALL MOLECULE INHIBITORS; THERAPEUTICS;

ANTI-BACTERIAL AGENTS; BIOFILMS; DRUG RESISTANCE, MICROBIAL; PSEUDOMONAS AERUGINOSA;

EID: 84891736535     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2013.11.001     Document Type: Review

References (95)

1. Balasubramanian D., Schneper L., Kumari H., Mathee K. Adynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence. Nucleic Acids Res 2013, 41:11-20.
2. Hidron A.I., Edwards J.R., Patel J., Horan T.C., Sievert D.M., Pollock D.A., et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the centers for disease control and prevention, 2006-2007. Infect Control Hosp Epidemiol 2008, 29:996-1011.
3. Kerr K.G., Snelling A.M. Pseudomonas aeruginosa: a formidable and ever-present adversary. JHosp Infect 2009, 73:338-344.
4. Manfredi R., Nanetti A., Ferri M., Chiodo F. Pseudomonas spp. complications in patients with HIV disease: an eight-year clinical and microbiological survey. Eur J Epidemiol 2000, 16:111-118.
5. Bouza E., Burillo A., Munoz P. Catheter-related infections: diagnosis and intravascular treatment. Clin J Sci Microbiol Infect 2002, 8:265-274.
6. Valderrey A.D., Pozuelo M.J., Jiménez P.A., Maciá M.D., Oliver A., Rotger R. Chronic colonization by Pseudomonas aeruginosa of patients with obstructive lung diseases: cystic fibrosis, bronchiectasis, and chronic obstructive pulmonary disease. Diagn Microbiol Infect Dis 2010, 68:20-27.
7. Mah T.F., Pitts B., Pellock B., Walker G.C., Stewart P.S., O'Toole G.A. Agenetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 2003, 426:306-310.
8. Lewis K. Persister cells, dormancy and infectious disease. Nat Rev Micro 2007, 5:48-56.
9. O'Toole G., Kaplan H.B., Kolter R. Biofilm formation as microbial development. Annu Rev Microbiol 2000, 54:49-79.
10. Hoiby N., Ciofu O., Bjarnsholt T. Pseudomonas aeruginosa biofilms in cystic fibrosis. Future Microbiol 2010, 5:1663-1674.
11. Favre-Bonté S., Chamot E., Köhler T., Romand J.A., Van Delden C. Auto inducer production and quorum-sensing dependent phenotypes of Pseudomonas aeruginosa vary according to isolation site during colonization of incubated patients. JSci BMC Microbiol 2010, 8:623-633.
12. Ganguly K., Wu R., Ollivault-Shiflett M., Goodwin P.M., Silks L.A., Iyer R. Design, synthesis, and a novel application of quorum-sensing agonists as potential drug-delivery vehicles. JDrug Target 2011, 19:528-539.
13. Storz M.P., Maurer C.K., Zimmer C., Wagner N., Brengel C., de Jong J.C., et al. Validation of PqsD as an anti-biofilm target in Pseudomonas aeruginosa by development of small-molecule inhibitors. JAm Chem Soc 2012, 134:16143-16146.
14. Stoodley P., Sauer K., Davies D.G., Costerton J.W. Biofilms as complex differentiated communities. Annu Rev Microbiol 2002, 56:187-209.
15. Klein T., Henn C., de Jong J.C., Zimmer C., Kirsch B., Maurer C.K., et al. Identification of small-molecule antagonists of the Pseudomonas aeruginosa transcriptional regulator PqsR: biophysically guided hit discovery and optimization. ACS Chem Biol 2012, 7:1496-1501.
16. Frank D.W. The exoenzyme S regulon of Pseudomonas aeruginosa. Mol Microbiol 1997, 26:621-629.
17. Musken M., Di Fiore S., Dotsch A., Fischer R., Haussler S. Genetic determinants of Pseudomonas aeruginosa biofilm establishment. Microbiology 2010, 156:431-441.
18. Fuqua W.C., Winans S.C., Greenberg E.P. Quorum sensing in bacteria: the LuxR-LuxI family of cell density-responsive transcriptional regulators. JBacteriol 1994, 176:269-275.
19. Pesci E.C., Milbank J.B., Pearson J.P., McKnight S., Kende A.S., Greenberg E.P., et al. Quinolone signaling in the cell-to-cell communication system of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 1999, 96:11229-11234.
20. McKnight S.L., Iglewski B.H., Pesci E.C. The Pseudomonas quinolone signal regulates rhl quorum sensing in Pseudomonas aeruginosa. JBacteriol 2000, 182:2702-2708.
21. Cao H., Krishnan G., Goumnerov B., Tsongalis J., Tompkins R., Rahme L.G. Aquorum sensing-associated virulence gene of Pseudomonas aeruginosa encodes a LysR-like transcription regulator with a unique self-regulatory mechanism. JSci Proc Natl Acad Sci U S A 2001, 98:14613-14618.
22. Diggle S.P., Cornelis P., Williams P., Camara M. 4-Quinolone signalling in Pseudomonas aeruginosa: old molecules, new perspectives. JSci Med Microbiol 2006, 296:83-91.
23. Diggle S.P., Winzer K., Chhabra S.R., Worrall K.E., Camara M., Williams P. The Pseudomonas aeruginosa quinolone signal molecule overcomes the cell density-dependency of the quorum sensing hierarchy, regulates rhl-dependent genes at the onset of stationary phase and can be produced in the absence of LasR. JSci Mol Microbiol 2003, 50:29-43.
24. Gambello M.J., Iglewski B.H. Cloning and characterization of Pseudomonas aeruginosa LasR gene, a transcriptional activator of elastase expression. JBacteriol 1991, 173:3000-3009.
25. Pearson J.P., Gray K.M., Passador L., Tucker K.D., Eberhand A., Iglwski B.H., et al. Structure of autoinducer required for expression of Pseudomonas aeruginosa virulence genes. Proc Natl Acad Sci U S A 1994, 91:197-201.
26. Gambello M.J., Kaye S., Iglewski B.H. LasR of Pseudomonas aeruginosa is a transcriptional activator of alkaline protease gene (apr) and an enhancer of exotoxin A expression. Infect Immun 1993, 61:1180-1184.
27. Friedman L., Kolter R. Genes involved in matrix formation in Pseudomonas aeruginosa PA14 biofilm. JSci Mol Microbiol 2004, 51:675-690.
28. Allesen-Holm H., Barken K.B., Yang L., Klausen M., Webb J.S., Kjelleberg S., et al. Acharacterization of DNA release in Pseudomonas aeruginosa cultures and biofilms. JSci Mol Microbiol 2006, 59:1114-1128.
29. Sakuragi Y., Kolter R. Quorum sensing regulation of the biofilm matrix genes (pel) of Pseudomonas aeruginosa. JBacteriol 2007, 189:5383-5386.
30. Ma L., Conover M., Lu H., Parsek M.R., Bayles K., Wozniak D.J. Assembly and development of Pseudomonas aeruginosa biofilm matrix. PLoS Pathog 2009, 5(3):1000354.
31. Coulon C., Vinogrador E., Filloux A., Sadovskaya I. Chemical analysis of cellular and extracellular carbohydrates of a biofilm forming strain Pseudomonas aeruginosa PA14. JSci PLoS One 2010, 5(12):e14220.
32. Ochsner U.A., Fiechter A., Reiser J. Isolation characterization in Escherichia coli of the Pseudomonas aeruginosa rhlAB genes encoding rhamnosyl transferase involved in rhamnolipid biosurfactant synthesis. JBiol Chem 1994, 269:19787-19795.
33. Pamp S.J., Tolker-Nielson T. Multiple roles of biosurfactants in structural biofilm development by Pseudomonas aeruginosa. JBacteriol 2007, 189:2531-2539.
34. Davey M.E., Caiazza N.C., O'Toole G.A. Rhamnolipid surfactant production affects biofilm architecture in Pseudomonas aeruginosa PAO1. JSci Bacteriol 2003, 185:1027-1036.
35. Van Delden C., Iglewski B.H. Cell to cell signaling and Pseudomonas aeruginosa infections. Emerg Infect Dis 1998, 4:551-560.
36. Loewen P.C., Hengge-Arorus R. The role of sigma factor sigma S (KatF) in bacterial global regulation [review]. Annu Rev Microbiol 1994, 48:53-80.
37. Latifi A., Foglino M., Tanaka K., Williams P., Lazdunski A. Ahierarchial quorum sensing cascade in Pseudomonas aeruginosa links transcriptional activators lasR and RhlR (vsmR) to expression of the stationary phase sigma factor RpoS. Mol Microbiol 1996, 21:1137-1146.
38. Pesci E., Pearson J., Seed P.C., Iglewski B.H. Regulation of las and rhl quorum sensing in Pseudomonas aeruginosa. JBacteriol 1997, 179:3127-3132.
39. Davies D.G., Parsek M.R., Pearson J.P., Iglewski B.H., Costerton J.W., Greenburg E.P. The involvement of cell to cell signals in the development of a bacterial biofilm. Science 1998, 280:295-298.
40. Deziel E., Lepine F., Milot S., He J., Mindrinos M.N., Tompkins R.G. Analysis of Pseudomonas aeruginosa 4-hydroxy-2-alkylquinolines (HAQs) reveals a role for 4-hydroxy-2-heptylquinoline in cell-to-cell communication. Proc Natl Acad Sci U S A 2004, 101:1339-1344.
41. Mashburn L.M., Whiteley M. Membrane vesicles traffic signals and facilitates group activities in a prokaryote. Nature 2005, 437:422-425.
42. Wade D.S., Calfee M.W., Rocha E.R., Ling E.A., Engstrom E., Coleman J.P. Regulation of Pseudomonas quinolone signal synthesis in Pseudomonas aeruginosa. JBacteriol 2005, 187:4372-4380.
43. Tsuneda S., Aikawa H., Hayashi H., Yuasa A., Hirata A. Extracellular polymeric substances responsible for bacterial adhesion onto solid surface. FEMS Microbiol Lett 2003, 223:287-292.
44. Flemming H.C., Wingender J. The biofilm matrix. Nat Rev Microbiol 2010, 8:623-633.
45. Ohman D.E. Molecular genetics of exopolysaccharide production by mucoid Pseudomonas aeruginosa. JClin Microbiol 1986, 5:6-10.
46. Stover C.K., Pham X.Q., Erwin A.L., Mizoguchi S.D., Warrener P., Hickey M.J. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 2000, 406:959-964.
47. Byrd M.S., Sadovskaya I., Vinogradov E., Lu H., Sprinkle A.B., Richardson S.H., et al. Genetic and biochemical analysis of Pseudomonas aeruginosa Psl exopolysaccharide reveal overlapping roles for polysaccharide synthesis enzymes in Psl and LPS production. Mol Microbiol 2009, 73:622-638.
48. Franklin M.J., Nivens D.E., Weadge J.T., Howell P.L. Biosynthesis of Pseudomonas aeruginosa extracellular polysaccharides alginate, Pel, Psl. Front Microbiol 2011, 2:56-67.
49. Das T., Manefield M. Pyocyanin promotes extracellular DNA release in Pseudomonas aeruginosa. PLoS One 2012, 7(10):e46718.
50. Whitchurch C.B., Tolker-Nielson T., Ragas P.C., Mattick J.S. Extracellular DNA required for bacterial biofilm formation 2002, 295:1487.
51. de Kievit T.R. Quorum sensing in Pseudomonas aeruginosa biofilms. Environ Microbiol 2009, 11:279-288.
52. Stewart P.S., Costerton J.W. Antibiotic resistance of bacteria in biofilms. The Lancet 2001, 358:135-138.
53. Walsh C. Molecular mechanisms that confer antibacterial drug resistance. Nature 2000, 406:775-781.
54. Mah T.F., O'Toole G.A. Mechanism of biofilm resistance to antimicrobial agents. Trends Microbiol 2001, 9:34-39.
55. Stewart P.S. Theoretical aspects of antibiotic diffusion into microbial biofilms. Antimicrobial Agents Chemother 1996, 40:2517-2522.
56. Anderl J.N., Franklin M.J., Stewart P.S. Role of antibiotic penetration limitation in Klebsiella pneumonias biofilm resistance to ampicillin and ciprofloxacin. Antimicrobial Agents Chemother 2000, 44:1818-1824.
57. Kumon H., Tomocika K., Matunaga T., Ogawa M., Ohmon H. Asandwich cup method for preparation assay of antimicrobial agents through Pseudomonas exopolysaccharides. Microbiol Immunol 1994, 8:615-619.
58. Shigeta M., Tanaka G., Komatsuzawa H., Sugai M., Suginaka H., Usui T. Permeation of antimicrobial agents through Pseudomonas aeruginosa biofilms: a simple method. Chemotherapy 1997, 43:340-345.
59. Nichols W.W., Dorrington S.M., Slack M.P.E., Walmsley H.L. Inhibition of tobramycin diffusion by binding to alginate. Antimicrobial Agents Chemother 1988, 32:618-623.
60. Gordon C.A., Hodges N.A., Marriott C. Antibiotic interaction and diffusion through alginate and exopolysaccharide of cystic fibrosis derived Pseudomonas aeruginosa. JAntimicrob Chemother 1998, 22:667-674.
61. De Beer D., Stoodley P., Roe F., Lewandowski Z. Effects of biofilm structure on oxygen distribution and mass transport. Biotechnol Bioeng 1994, 43:1131-1138.
62. Tack K.J., Sabath L.D. Increased minimum inhibitory concentration with anaerobiasis for tobramycin, gentamycin and amikacin compared to latamoxey, piperacillin, chloramphenicol and clindamycin. Chemotherapy 1985, 31:204-210.
63. Tuomanen E., Cozens R., Tosch W., Zak O., Tomasz A. The rate of killing Escherichia coli b β lactam antibiotics is strictly proportional to the rate of bacterial growth. JGen Microbiol 1986, 132:1297-1304.
64. Prigent-Combaret C., Vidal O., Dorel C., Lejeune P. Abiotic surface sensing and biofilm development regulation of gene expression in Escherichia coli. JBacteriol 1999, 181:5993-6002.
65. das J.R., Bhakoo M., Jones M.V., Gilbert P. Changes in the biocide susceptibility of Staphylococcus epidermis and Escherichia coli cells associated with rapid attachment to plastic surfaces. JAppl Microbiol 1998, 84:52-58.
66. Cochran W.L., McFeters G.A., Stewart P.S. Reduced susceptibility of thin Pseudomonas aeruginosa biofilms to hydrogen peroxide and monochloramine. JAppl Microbiol 2000, 88:22-30.
67. Sadikot R.T., Blackwell T.S., Christman J.W., Prince A.S. Pathogen-host Interactions in Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med 2005, 171:1209-1223.
68. Kipnis E., Sawa T., Wiener-Kronish J. Targeting mechanisms of Pseudomonas aeruginosa pathogenesis. Med Mal Infect 2006, 36:78-91.
69. Coburn B., Sekirov I., Finlay B.B. Type III secretion systems and disease. Clin Microbiol Rev 2007, 20:535-549.
70. Yahr T.L., Mende-Mueller L.M., Friese M.B., Frank D.W. Identification of type III secreted products of the Pseudomonas aeruginosa exoenzyme S regulon. JBacteriol 1997, 179:7165-7168.
71. Hauser A.R., Fleiszig S., Kang P.J., Mostov K., Engel J.N. Defects in type III secretion correlate with internalization of Pseudomonas aeruginosa by epithelial cells. Infect Immun 1998, 66:1413-1420.
72. Yamazaki A., Li J., Zeng O., Khokhani D., Hutchins W.C., Yost A.C. Derivatives of plant phenolic compound affects the type III secretion system of Pseudomonas aeruginosa via a GacS-GacA two-component signal transduction system. Antimicrobial Agents Chemother 2012, 56:36-43.
73. Veesenmeyer J.L., Hauser A.R., Lisboa T., Rello J. Pseudomonas aeruginosa virulence and therapy: evolving translational strategies. Crit Care Med 2009, 37:1777-1786.
74. Aiello D., Williams J.D., Majgier-Baranowska H., Patel N.P.I., Huang J. Discovery and characterization of inhibitors of Pseudomonas aeruginosa type III secretion. JSci Antimicrob Agents Chemother 2010, 54:1988-1999.
75. Zeng Z., Qian L., Cao L., Tan H., Huang Y., Xue X. Virtual screening for novel quorum sensing inhibitors to eradicate biofilm formation of Pseudomonas aeruginosa. Appl Microbiol Biotechnol 2008, 79:119-126.
76. Jakobsen T.H., van Gennip M., Phipps R.K., Shanmugham M.S., Christensen L.D., Alhede M. Ajoene, a sulfur-rich molecule from garlic, inhibits genes controlled by quorum sensing. Antimicrobial Agents Chemother 2012, 56:2314-2325.
77. Digiandomenico A., Warrener P., Hamilton M., Guillard S., Ravn S., Minter R. Identification of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screening. JSci Exp Med 2012, 209:1273-1287.
78. Kaufmann G.F., Park J., Mayorov A.V., Kubitz D.M., Janda K.D. Generation of quorum quenching antibodies. Methods Mol Biol 2011, 692:299-311.
79. Morello E., Saussereau E., Maura D., Huerre M., Touqui L., Debarbieux L. Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention. PLoS One 2011, 6(2):e16963.
80. Alemayehu D., Casey P.G., McAuliffe O., Guinane C.M., Martin J.G., Shanahan F., et al. Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells. mBio 2012, 3:e00029-12.
81. Biel M.A., Sievert C., Usacheva M., Teichert M., Wedell E., Loebel N., et al. Reduction of endotracheal tube biofilms using antimicrobial photodynamic therapy. JSci Lasers Surg Med 2011, 4:586-590.
82. Chen C.P., Chen C.T., Tsai T. Chitosan nanoparticles for antimicrobial photodynamic inactivation: characterization and invitro investigation. JSci Photochem Photobiol 2007, 88:22-30.
83. Michel-Briand Y., Baysse C. The pyocins of Pseudomonas aeruginosa. Biochimie 2002, 84:499-510.
84. Kapoor R., Wadman W.M., Dohm M.T., Czyzewski A.M., Spormann A.M., Barron A.E. Antimicrobial peptoids are effective against Pseudomonas aeruginosa Biofilms. Antimicrobial Agents Chemother 2011, 55:3054-3057.
85. Dean S.N., Bishop B.N., van Hoek M.L. Susceptibility of Pseudomonas aeruginosa biofilm to Alpha-helical peptides: D-enantiomer of LL-37. JSci Front Microbiol 2011, 2:122-128.
86. Pompilio A., Crocetta V., Scocchi M., Pomponio S., Di Vincenzo V., Mardirossian M., et al. Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa and Stenotrophomonas maltophilia. BMC Microbiol 25 2012, 12:145.
87. Eckhart L., Fischer H., Barken K.B., Tolker-Nielsen T., Tschachler E. DNase1L2 suppress biofilm formation by Pseudomonas aeruginosa and Staphylococcus aureus. JSci Br J Dermatol 2007, 156(6):1342-1345.
88. Alkawash M.A., Soothill J.S., Schiller N.L. Alginate lyase enhances antibiotic killing of mucoid Pseudomonas aeruginosa in biofilms. JSci APMIS 2006, 114(2):131-138.
89. Ozer E.A., Pezzulo A., Shih D.M. Human and murine paraoxonase 1 are host modulators of Pseudomonas aeruginosa quorum-sensing. FEMS Microbiol Lett 2005, 253:29-37.
90. Yang F., Wang L.H., Wang J. Quorum quenching enzyme activity is widely conserved in the sera of mammalian species. FEBS Lett 2005, 579:3713-3717.
91. Stoltz D.A., Ozer E.A., Ng C.J., Yu J.M., Reddy S.T., Lusis A.J., et al. Paraoxonase-2 deficiency enhances Pseudomonas aeruginosa quorum sensing in murine tracheal epithelia. Am J Physiol Lung Cell Mol Physiol 2007, 292:852-860.
92. Kiran S., Sharma P., Harjai K., Capalash N. Enzymatic quorum quenching increases antibiotic susceptibility of multidrug resistant Pseudomonas aeruginosa. Iran J Microbiol 2011, 3:1-12.
93. Abdelghany S.M., Quinn D.J., Ingram R.J., Gilmore B.F., Donnelly R.F., Taggart C.C., et al. Gentamicin-loaded nanoparticles show improved antimicrobial effects towards Pseudomonas aeruginosa infection. J.Sci.Nanomedicine 2012, 7:4053-4063.
94. Kalishwaralal K., Barath ManiKanth S., Pandian S.R., Deepak V., Gurunathan S. Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis. Colloids Surf B 2010, 79:340-344.
95. Mohanty S., Mishra S., Jena P., Jacob B., Sarkar B., Sonawane A. An investigation on the antibacterial cytotoxic and antibiofilm efficacy of starch-stabilized silver nanoparticles. Nanomedicine 2012, 8:916-924.